Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
暂无分享,去创建一个
[1] N. Harper,et al. Optimum dose of neostigmine at two levels of atracurium-induced neuromuscular block. , 1994, British journal of anaesthesia.
[2] F. Donati,et al. Reversal of Neuromuscular Blockade , 1992, Anesthesiology.
[3] L. Barvais,et al. The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade. , 1992, Anesthesiology.
[4] D. Goldhill,et al. Antagonism of atracurium with neostigmine , 1991, Anaesthesia.
[5] A. Bjorksten,et al. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. , 1991, British journal of anaesthesia.
[6] W. Young,et al. Pharmacokinetics and pharmacodynamics of edrophonium in elderly surgical patients. , 1990 .
[7] R. Miller,et al. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? , 1990, Anesthesiology.
[8] L. Skovgaard,et al. Reversal of intense neuromuscular blockade following infusion of atracurium. , 1990, Anesthesiology.
[9] F. Donati,et al. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. , 1989, Anesthesiology.
[10] F. Donati,et al. Dose‐Response Relationships for Edrophonium and Neostigmine as Antagonists of Moderate and Profound Atracurium Blockade , 1989, Anesthesia and analgesia.
[11] J. Hunter,et al. Antagonism of blockade produced by atracurium or vecuronium with low doses of neostigmine. , 1988, British journal of anaesthesia.
[12] F. Donati,et al. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. , 1988, Anesthesiology.
[13] F. Donati,et al. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade , 1987 .
[14] R. Bartkowski. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. , 1987, Anesthesia and analgesia.
[15] F. Donati,et al. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine. , 1987 .
[16] E. Robertson,et al. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery. , 1987, British journal of anaesthesia.
[17] A. Kopman. Recovery Times Following Edrophonium and Neostigmine Reversal of Pancuronium, Atracurium, and Vecuronium Steady-state Infusions , 1986, Anesthesiology.
[18] Ronald D. Miller,et al. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium. , 1986 .
[19] G. Lavery,et al. A Comparison of Edrophonium and Neostigmine for the Antagonism of Atracurium‐Induced Neuromuscular Block , 1985, Anesthesia and analgesia.
[20] J. Williams,et al. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium. , 1984, British journal of anaesthesia.
[21] F. Donati,et al. Twitch Depression and Train‐of–Four Ratio after Antagonism of Pancuronium with Edrophonium, Neostigmine, or Pyridostigmine , 1983, Anesthesia and analgesia.
[22] R. Miller,et al. Edrophonium: Duration of Action and Atropine Requirement in Humans during Halothane Anesthesia , 1982, Anesthesiology.
[23] R. Miller,et al. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine. , 1982, British journal of anaesthesia.
[24] E. T. Abbs,et al. THE EFFECTS OF ATROPINE AND OXOTREMORINE ON ACETYLCHOLINE RELEASE IN RAT PHRENIC NERVE‐DIAPHRAGM PREPARATIONS , 1981, British journal of pharmacology.
[25] D. Bevan,et al. Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of Pancuronium , 1980, Anesthesiology.
[26] J. Viby-Mogensen,et al. Residual curarization in the recovery room. , 1979, Anesthesiology.
[27] E. Eger,et al. Comparative Times to Peak Effect and Durations of Action of Neostigmine and Pyridostigmine , 1974, Anesthesiology.